Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer
Publication Date: April 26, 2021
Key Points
Key Points
- The Panel continues to recommend that full, weight-based cytotoxic chemotherapy doses be used to treat obese adults with cancer.
- The Panel also recommends that full, approved doses of immunotherapy and targeted therapies be offered to obese adults with cancer.
- In the event of toxicity, the consensus of the Panel is that dose modifications of systemic antineoplastic therapies should be handled similarly for obese and non-obese patients.
Treatment
...reatme...
...ull weight-based dosing of cytotoxi...
...mmends limiting fixed dosing of chemother...
...prescribing information for checkpoint i...
...ed prescribing information for targ...
...an obese patient experiences high-grade t...
...he Panel recommends that BSA be calculated using...